# BGC Group, Inc.: financial statements, quarterly

BGC · Nasdaq · CIK 1094831 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bgc.md) · [Financials](/companies/bgc/financials.md) · [Filings](/companies/bgc/filings.md) · [Insiders](/companies/bgc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bgc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [386](/filings/0001628280-24-046648.md) | [426 d](/filings/0001628280-26-013162.md) | [454](/filings/0001628280-25-024645.md) | [435](/filings/0001628280-25-039532.md) | [449](/filings/0001628280-25-051029.md) | [475 d](/filings/0001628280-26-013162.md) | [535](/filings/0001628280-26-033499.md) | [648](/filings/0001628280-26-055187.md) | [621](/filings/0001628280-25-051029.md) | [639 d](/filings/0001628280-26-013162.md) | [798](/filings/0001628280-26-033499.md) | [696](/filings/0001628280-26-055187.md) |
| Interest expense | $m | [20.8](/filings/0001628280-23-038213.md) | [20.8 d](/filings/0001628280-24-007951.md) | [20.1](/filings/0001628280-24-022251.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [5.3](/filings/0001628280-24-046648.md) | [10.6 d](/filings/0001628280-26-013162.md) | [22.1](/filings/0001628280-25-024645.md) | [18.0](/filings/0001628280-25-039532.md) | [6.0](/filings/0001628280-25-051029.md) | [3.9 d](/filings/0001628280-26-013162.md) | [26.5](/filings/0001628280-26-033499.md) | [19.1](/filings/0001628280-26-055187.md) | [7.4](/filings/0001628280-25-051029.md) | [14.2 d](/filings/0001628280-26-013162.md) | [32.0](/filings/0001628280-26-033499.md) | [30.1](/filings/0001628280-26-055187.md) |
| Net income | $m | [17.0](/filings/0001628280-24-046648.md) | [22.5 d](/filings/0001213900-26-048621.md) | [49.2](/filings/0001628280-25-024645.md) | [37.8](/filings/0001628280-25-039532.md) | [14.7](/filings/0001628280-25-051029.md) | [21.4 d](/filings/0001213900-26-048621.md) | [55.2](/filings/0001628280-26-033499.md) | [57.5](/filings/0001628280-26-055187.md) | [27.9](/filings/0001628280-25-051029.md) | [14.4 d](/filings/0001628280-26-013162.md) | [84.1](/filings/0001628280-26-033499.md) | [72.5](/filings/0001628280-26-055187.md) |
| Diluted EPS | $ per share | [0.03](/filings/0001628280-24-046648.md) | not reported | [0.10](/filings/0001628280-25-024645.md) | [0.08](/filings/0001628280-25-039532.md) | [0.03](/filings/0001628280-25-051029.md) | not reported | [0.11](/filings/0001628280-26-033499.md) | [0.11](/filings/0001628280-26-055187.md) | [0.06](/filings/0001628280-25-051029.md) | not reported | [0.17](/filings/0001628280-26-033499.md) | [0.15](/filings/0001628280-26-055187.md) |
| Basic EPS | $ per share | [0.03](/filings/0001628280-24-046648.md) | not reported | [0.10](/filings/0001628280-25-024645.md) | [0.08](/filings/0001628280-25-039532.md) | [0.03](/filings/0001628280-25-051029.md) | not reported | [0.11](/filings/0001628280-26-033499.md) | [0.11](/filings/0001628280-26-055187.md) | [0.06](/filings/0001628280-25-051029.md) | not reported | [0.17](/filings/0001628280-26-033499.md) | [0.15](/filings/0001628280-26-055187.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [560](/filings/0001628280-23-038213.md) | [656](/filings/0001628280-25-009421.md) | [567](/filings/0001628280-24-022251.md) | [572](/filings/0001628280-24-035883.md) | [563](/filings/0001628280-24-046648.md) | [712](/filings/0001628280-26-013162.md) | [966](/filings/0001628280-25-024645.md) | [828](/filings/0001628280-25-039532.md) | [775](/filings/0001628280-25-051029.md) | [852](/filings/0001628280-26-055187.md) | [781](/filings/0001628280-26-033499.md) | [767](/filings/0001628280-26-055187.md) |
| Total assets | $m | [3,858](/filings/0001628280-23-038213.md) | [3,176](/filings/0001628280-25-009421.md) | [4,376](/filings/0001628280-24-022251.md) | [4,259](/filings/0001628280-24-035883.md) | [4,382](/filings/0001628280-24-046648.md) | [3,592](/filings/0001628280-26-013162.md) | [4,884](/filings/0001628280-25-024645.md) | [4,892](/filings/0001628280-25-039532.md) | [5,825](/filings/0001628280-25-051029.md) | [4,412](/filings/0001628280-26-055187.md) | [5,859](/filings/0001628280-26-033499.md) | [5,751](/filings/0001628280-26-055187.md) |
| Total liabilities | $m | [3,003](/filings/0001628280-23-038213.md) | [2,278](/filings/0001628280-25-009421.md) | [3,451](/filings/0001628280-24-022251.md) | [3,217](/filings/0001628280-24-035883.md) | [3,339](/filings/0001628280-24-046648.md) | [2,513](/filings/0001628280-26-013162.md) | [3,742](/filings/0001628280-25-024645.md) | [3,783](/filings/0001628280-25-039532.md) | [4,683](/filings/0001628280-25-051029.md) | [3,267](/filings/0001628280-26-055187.md) | [4,587](/filings/0001628280-26-033499.md) | [4,477](/filings/0001628280-26-055187.md) |
| Long-term debt | $m | [1,183](/filings/0001628280-23-038213.md) | [1,184](/filings/0001628280-25-009421.md) | [945](/filings/0001628280-24-022251.md) | [1,441](/filings/0001628280-24-035883.md) | [1,441](/filings/0001628280-24-046648.md) | [1,338](/filings/0001628280-26-013162.md) | [1,689](/filings/0001628280-25-024645.md) | [1,918](/filings/0001628280-25-039532.md) | [1,837](/filings/0001628280-25-051029.md) | [1,776](/filings/0001628280-26-055187.md) | [1,777](/filings/0001628280-26-033499.md) | [1,774](/filings/0001628280-26-055187.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-013162.md) | not reported | not reported | not reported | [20.0](/filings/0001628280-26-055187.md) | [0.0](/filings/0001628280-26-033499.md) | [0.0](/filings/0001628280-26-055187.md) |
| Shareholders' equity | $m | [844](/filings/0001628280-23-038213.md) | [885](/filings/0001628280-25-009421.md) | [912](/filings/0001628280-24-022251.md) | [858](/filings/0001628280-24-035883.md) | [860](/filings/0001628280-24-046648.md) | [899](/filings/0001628280-26-013162.md) | [964](/filings/0001628280-25-024645.md) | [930](/filings/0001628280-25-039532.md) | [965](/filings/0001628280-25-051029.md) | [972](/filings/0001628280-26-055187.md) | [1,100](/filings/0001628280-26-033499.md) | [1,106](/filings/0001628280-26-055187.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [313 d](/filings/0001628280-24-046648.md) | [174 d](/filings/0001628280-26-013162.md) | [28.1](/filings/0001628280-25-024645.md) | [(53.0) d](/filings/0001628280-25-039532.md) | [88.3 d](/filings/0001628280-25-051029.md) | [252 d](/filings/0001628280-26-013162.md) | [0.8](/filings/0001628280-26-033499.md) | [71.2 d](/filings/0001628280-26-055187.md) | [142 d](/filings/0001628280-25-051029.md) | [180 d](/filings/0001628280-26-013162.md) | [20.2](/filings/0001628280-26-033499.md) | [162 d](/filings/0001628280-26-055187.md) |
| Capital expenditure | $m | [2.0 d](/filings/0001628280-24-046648.md) | [5.8 d](/filings/0001628280-26-013162.md) | [3.2](/filings/0001628280-25-024645.md) | [10.5 d](/filings/0001628280-25-039532.md) | [9.6 d](/filings/0001628280-25-051029.md) | [6.3 d](/filings/0001628280-26-013162.md) | [5.3](/filings/0001628280-26-033499.md) | [6.3 d](/filings/0001628280-26-055187.md) | [4.7 d](/filings/0001628280-25-051029.md) | [5.3 d](/filings/0001628280-26-013162.md) | [4.8](/filings/0001628280-26-033499.md) | [4.9 d](/filings/0001628280-26-055187.md) |
| Dividends paid | $m | [4.7 d](/filings/0001628280-24-046648.md) | [5.1 d](/filings/0001628280-26-013162.md) | [4.8](/filings/0001628280-25-024645.md) | [9.8 d](/filings/0001628280-25-039532.md) | [9.8 d](/filings/0001628280-25-051029.md) | [9.7 d](/filings/0001628280-26-013162.md) | [9.9](/filings/0001628280-26-033499.md) | [9.7 d](/filings/0001628280-26-055187.md) | [9.8 d](/filings/0001628280-25-051029.md) | [9.7 d](/filings/0001628280-26-013162.md) | [9.7](/filings/0001628280-26-033499.md) | [9.7 d](/filings/0001628280-26-055187.md) |
| Share repurchases | $m | [40.1 d](/filings/0001628280-24-046648.md) | [28.0 d](/filings/0001628280-26-013162.md) | [68.6](/filings/0001628280-25-024645.md) | [79.5 d](/filings/0001628280-25-039532.md) | [64.1 d](/filings/0001628280-25-051029.md) | [50.0 d](/filings/0001628280-26-013162.md) | [23.1](/filings/0001628280-26-033499.md) | [149 d](/filings/0001628280-26-055187.md) | [41.9 d](/filings/0001628280-25-051029.md) | [68.0 d](/filings/0001628280-26-013162.md) | [2.3](/filings/0001628280-26-033499.md) | [112 d](/filings/0001628280-26-055187.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [497](/filings/0001628280-23-038213.md) | [501](/filings/0001628280-24-022251.md) | [392](/filings/0001628280-24-035883.md) | [478](/filings/0001628280-24-046648.md) | [478](/filings/0001628280-25-024645.md) | [481](/filings/0001628280-25-039532.md) | [479](/filings/0001628280-25-051029.md) | [486](/filings/0001628280-26-033499.md) | [485](/filings/0001628280-26-055187.md) | [478](/filings/0001628280-25-051029.md) | [479](/filings/0001628280-26-033499.md) | [479](/filings/0001628280-26-055187.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.